Connecting nephrology and cardiology has taken on huge importance. In this episode of Connecting Heart and Kidney, host Janani Rangaswami speaks with a panel of trailblazers and thought leaders in the fields of cardiology, nephrology, physiology, and endocrinology, about the rise of the SGLT2 inhibitors as a game changing therapy for cardiovascular disease, the trajectory of renalism given recent trials, addressing structural inequities in cardiorenal trials, and much more. Listen and learn about the many ways that heart health and kidney health are intertwined.
Learn more about AHA professional membership and the Council on Kidney in Cardiovascular Disease at: https://professional.heart.org/kcvdcouncil
Follow Us
- Twitter @AHAScience
- LinkedIn: https://www.linkedin.com/company/american-heart-association
Presented by the American Heart Association
www.heart.org